BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24919955)

  • 1. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma.
    Ren K; Yao N; Wang G; Tian L; Ma J; Shi X; Zhang L; Zhang J; Zhou X; Zhou G; Wu S; Sun X
    Hum Pathol; 2014 Oct; 45(10):2120-9. PubMed ID: 25123071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma.
    Yuan D; Liu B; Liu K; Zhu G; Dai Z; Xie Y
    J Surg Oncol; 2013 Sep; 108(3):157-62. PubMed ID: 23813624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of RANK signalling on survival and chemotherapy response in osteosarcoma.
    Bago-Horvath Z; Schmid K; Rössler F; Nagy-Bojarszky K; Funovics P; Sulzbacher I
    Pathology; 2014 Aug; 46(5):411-5. PubMed ID: 24842377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF signaling pathway analysis of osteosarcomas reveals the prognostic value of pAKT localization.
    van de Luijtgaarden AC; Roeffen MH; Leus MA; Flucke UE; Schreuder BH; van der Graaf WT; Versleijen-Jonkers YM
    Future Oncol; 2013 Nov; 9(11):1733-40. PubMed ID: 24156333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer.
    Fohlin H; Pérez-Tenorio G; Fornander T; Skoog L; Nordenskjöld B; Carstensen J; Stål O
    Eur J Cancer; 2013 Apr; 49(6):1196-204. PubMed ID: 23305873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APEX1 gene amplification and its protein overexpression in osteosarcoma: correlation with recurrence, metastasis, and survival.
    Yang J; Yang D; Cogdell D; Du X; Li H; Pang Y; Sun Y; Hu L; Sun B; Trent J; Chen K; Zhang W
    Technol Cancer Res Treat; 2010 Apr; 9(2):161-9. PubMed ID: 20218738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of MMP-2 expression and prognosis in osteosarcoma patients.
    Zhang M; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
    Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
    Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcome.
    Salas S; Huynh TK; Giorgi R; Deville JL; Bollini G; Curvale G; Blesius A; Gentet JC; Bui B; Bouvier C; Duffaud F
    Eur J Cancer Care (Engl); 2011 May; 20(3):322-9. PubMed ID: 20148934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.